Every super-investor and insider move tracked across 241 tickers in this industry.
| # | Manager | Sector value |
|---|---|---|
| 1 | T. Rowe Price | $14.89B |
| 2 | Wellington Management | $12.45B |
| 3 | Dodge & Cox | $6.85B |
| 4 | Norges Bank Norway SWF | $6.32B |
| 5 | Ken Griffin Citadel Advisors | $4.58B |
| 6 | D.E. Shaw & Co. | $3.92B |
| 7 | AQR Capital Management | $3.92B |
| 8 | Steve Cohen Point72 | $3.62B |
| 9 | Izzy Englander Millennium Mgmt | $3.50B |
| 10 | Renaissance Technologies | $2.99B |
| 11 | Two Sigma Investments | $2.79B |
| 12 | Andreas Halvorsen Viking Global | $2.42B |
| # | Ticker | Company | Value |
|---|---|---|---|
| 1 | REGN | REGENERON PHARMACEUTICALS | $8.53B |
| 2 | VRTX | VERTEX PHARMACEUTICALS INC | $4.99B |
| 3 | ALNY | ALNYLAM PHARMACEUTICALS INC | $4.90B |
| 4 | ARGX | ARGENX SE | $4.43B |
| 5 | INSM | INSMED INC | $3.00B |
| 6 | INCY | INCYTE CORP | $2.76B |
| 7 | BMRN | BIOMARIN PHARMACEUTICAL INC | $2.58B |
| 8 | BBIO | BRIDGEBIO PHARMA INC | $2.10B |
| 9 | MDGL | MADRIGAL PHARMACEUTICALS INC | $1.78B |
| 10 | EXEL | EXELIXIS INC | $1.56B |
| 11 | RVMD | REVOLUTION MEDICINES INC | $1.44B |
| 12 | IONS | IONIS PHARMACEUTICALS INC | $1.24B |
| 13 | TECH | BIO-TECHNE CORP | $1.21B |
| 14 | MRNA | MODERNA INC | $1.13B |
| 15 | ASND | ASCENDIS PHARMA A/S | $958.3M |
| 16 | ONC | ONCOLYTICS BIOTECH INC | $910.9M |
| 17 | KYMR | KYMERA THERAPEUTICS INC | $873.6M |
| 18 | CYTK | CYTOKINETICS INC | $869.4M |
| 19 | AXSM | AXSOME THERAPEUTICS INC | $809.6M |
| 20 | CRNX | CRINETICS PHARMACEUTICALS IN | $789.6M |
| 21 | PTCT | PTC THERAPEUTICS INC | $716.2M |
| 22 | SRRK | SCHOLAR ROCK HLDG CORP | $708.1M |
| 23 | GPCR | STRUCTURE THERAPEUTICS INC | $693.6M |
| 24 | ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $684.6M |